Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
September 30, 2026 -1.142M
June 30, 2026 -2.909M
March 31, 2026 -1.759M
December 31, 2025 -2.028M
September 30, 2025 -1.931M
June 30, 2025 -2.322M
March 31, 2025 -1.562M
December 31, 2024 -2.448M
September 30, 2024 -1.827M
June 30, 2024 -0.9629M
March 31, 2024 -1.964M
December 31, 2023 -1.817M
September 30, 2023 -2.174M
June 30, 2023 -0.7367M
March 31, 2023 -1.655M
December 31, 2022 -2.618M
September 30, 2022 -2.256M
June 30, 2022 -3.989M
March 31, 2022 -5.274M
December 31, 2021 -3.532M
September 30, 2021 -2.654M
June 30, 2021 -2.198M
March 31, 2021 -5.598M
December 31, 2020 -1.063M
September 30, 2020 -1.372M
Date Value
June 30, 2020 -1.244M
March 31, 2020 -1.471M
December 31, 2019 -2.066M
September 30, 2019 -2.365M
June 30, 2019 -1.768M
March 31, 2019 -2.077M
December 31, 2018 -1.391M
September 30, 2018 -1.317M
June 30, 2018 -1.006M
March 31, 2018 -0.7511M
December 31, 2017 -0.786M
September 30, 2017 -1.076M
June 30, 2017 -0.7358M
March 31, 2017 -0.7426M
December 31, 2016 -0.6439M
September 30, 2016 -0.1663M
June 30, 2016 -0.1126M
March 31, 2016 -0.0349M
December 31, 2015 -0.1092M
September 30, 2015 -0.1308M
June 30, 2015 -0.755M
March 31, 2015 -0.6728M
December 31, 2014 -0.0881M
September 30, 2014 -0.1053M
June 30, 2014 -0.6247M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Liquidia Corp. 146.68M
Johnson & Johnson 7.72B
Eli Lilly & Co. 11.40B
Merck & Co., Inc. 6.558B
ANI Pharmaceuticals, Inc. 83.79M